C12N

Biotech / Gene Therapy

USPTO Patent Applications

← All categories

159 items

Application

Cd127 Expression Inversely Correlates With Foxp3 And Suppressive Function Of Cd4+ Tregs

US20260079159A1 · Mar 19, 2026
G01N A61K
Application

Generation Of Mature Neurons Differentiated From Pluripotent Stem Cells

US20260079153A1 · Mar 19, 2026
G01N C12N
Application

Three Dimensional Immunomechanical Organoid Model

US20260079151A1 · UNIVERSITY OF NOTRE DAME DU LAC · Mar 19, 2026
G01N C12N
Application

Apparatus, System, And Method For High Yield Magnetic Separation Of A Biological Population

US20260079086A1 · Mar 19, 2026
G01N C12N
Application

Volatile Organic Compounds As Markers For Cellular Communication

US20260079169A1 · Mar 19, 2026
G01N C12N
Application

Method For Characterizing And Engineering Protein Protein Interactions

US20260079163A1 · A-Alpha Bio, Inc. · Mar 19, 2026
G01N C12N
Application

Ore Breaker Compositions And Methods For Biological Enrichment Of Metals

US20260078464A1 · ECOBIOME HOLDINGS LLC · Mar 19, 2026
C22B C12N
Application

Multiple Antibiotic Bacterial Response

US20260078454A1 · Mar 19, 2026
C12Q B01L
Application

Detecting Ovarian Cancer

US20260078450A1 · Mar 19, 2026
C12Q C12N
Application

Enzymes, Micro Organisms And Uses Thereof, And A Method Of Degrading Hydrocarbon Chains

US20260078233A1 · Mar 19, 2026
C08J C12N
Application

Genetically Modified Non Human Animals And Methods For Producing Heavy Chain Antibodies

US20260078197A1 · Mar 19, 2026
C07K A01K
Application

Methods And Compositions For Increasing Iduronate 2 Sulfatase Activity In The Cns

US20260078178A1 · Mar 19, 2026
C07K C07K
Application

Hcv Antigens And Antibodies

US20260078172A1 · Mar 19, 2026
C07K A61K
Application

Anti Dll3 Chimeric Antigen Receptors And Uses Thereof

US20260078166A1 · Mar 19, 2026
C07K A61K
Application

Processes For Generating Engineered Cells And Compositions Thereof

US20260078165A1 · Juno Therapeutics, Inc. · Mar 19, 2026
C07K A61K
Application

Next Generation Sequencing Pipeline For Detection Of Ultrashort Single Stranded Cell Free Dna

US20260078439A1 · Mar 19, 2026
C12Q C12N
Application

Rolling Circle Amplification Method, Method For Preparing Sequencing Library, And Dna Nanosphere Prepared Therefrom

US20260078431A1 · Mar 19, 2026
C12Q C12N
Application

Whole Blood Cryopreservation And Processing Method For Single Cell Rna Sequencing

US20260078428A1 · THE BROAD INSTITUTE, INC. · Mar 19, 2026
C12Q C12N
Application

Method For Preparing Oligonucleotide By Using Rna Ligase

US20260078424A1 · Mar 19, 2026
C12P C12N
Application

Microorganisms For The Production Of Low Calorie Sugars

US20260078422A1 · Mar 19, 2026
C12P C12N
Application

Compositions And Methods For The Production Of 1,2 Beta Oligoglucans

US20260078420A1 · Cargill, Incorporated · Mar 19, 2026
C12P C08B
Application

A Method Of Making An Ethanol Composition And A Separate Galactose Composition By Fermentation

US20260078418A1 · Mar 19, 2026
C12P B01D
Application

Transaminase Biocatalysts

US20260078417A1 · Codexis, Inc. · Mar 19, 2026
C12P C12N
Application

Orthogonal Metabolic Framework For One Carbon Utilization

US20260078416A1 · Mar 19, 2026
C12P C12N
Application

Differential Knockout Of An Allele Of A Heterozygous Elane Gene

US20260078415A1 · Mar 19, 2026
C12N A61K
Application

Materials And Methods For Treatment Of Pain Related Disorders

US20260078414A1 · Vertex Pharmaceuticals Incorporated · Mar 19, 2026
C12N A61K
Application

Methods And Products For Expressing Proteins In Cells

US20260078413A1 · Mar 19, 2026
C12N A61K
Application

Endonuclease Systems

US20260078412A1 · Mar 19, 2026
C12N C12N
Application

Novel Genomic Safe Harbor And Use Thereof

US20260078411A1 · Mar 19, 2026
C12N C07K
Application

Nanoscopic Projectiles

US20260078410A1 · Mar 19, 2026
C12N C12N
Application

Methods And Products For Transfecting Cells

US20260078409A1 · Mar 19, 2026
C12N A61K
Application

Muscle Specific Expression Cassettes

US20260078408A1 · Precision BioSciences, Inc. · Mar 19, 2026
C12N A61K
Application

Raav Vectors For The Treatment Of Gm1 And Gm2 Gangliosidosis

US20260078407A1 · Mar 19, 2026
C12N A61P
Application

Gene Therapy For Ceroid Lipofuscinoses

US20260078406A1 · Mar 19, 2026
C12N A61K
Application

Gene Therapy For Treating Citrullenemia

US20260078405A1 · The Trustees of the University of Pennsylvania · Mar 19, 2026
C12N A61P
Application

Compositions And Methods For Selective Gene Regulation

US20260078404A1 · Mar 19, 2026
C12N A61P
Application

Zikv Based Gene Delivery System

US20260078403A1 · Mar 19, 2026
C12N A61K
Application

Transposon System And Methods Of Using The Same

US20260078402A1 · Mar 19, 2026
C12N A23L
Application

Scarless Genome Editing Through Two Step Homology Directed Repair

US20260078401A1 · The Board of Trustees of the Leland Stanford Junior University · Mar 19, 2026
C12N C12N
Application

Circular Rna For Translation In Eukaryotic Cells

US20260078400A1 · Mar 19, 2026
C12N C07K
Application

Use Of Glycine Soja Zinc Finger Protein 4 (Gs Zfp4) Or Genetic Material Thereof

US20260078399A1 · Mar 19, 2026
C12N C07K
Application

Plants Genetically Engineered For Increased Water Use Efficiency And Carbon Intake And Methods For Making And Using Them

US20260078398A1 · Mar 19, 2026
C12N C07K
Application

Methods For Controlling Meristem Size For Crop Improvement

US20260078397A1 · Mar 19, 2026
C12N C12N
Application

Green Algal Bestrophin Bicarbonate Transporters

US20260078396A1 · Board of Supervisors of Louisiana State University and Agricultural and Mechanical College · Mar 19, 2026
C12N C12N
Application

Compositions And Methods For Protein Production

US20260078395A1 · Mar 19, 2026
C12N C07K
Application

Methods And Compositions For Improving Plant Architecture And Yield Traits

US20260078394A1 · Mar 19, 2026
C12N A01H
Application

Plants With Increased Photorespiration Efficiency

US20260078393A1 · The United States of America, as Represented by the Secretary of Agriculture · Mar 19, 2026
C12N C12N
Application

Genome Editing Method For Duplicated Genes

US20260078392A1 · NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY · Mar 19, 2026
C12N C12N
Application

Genetically Enhanced Maize Plants

US20260078391A1 · Mar 19, 2026
C12N C12N
Application

Thph2 Protein From Trichoderma Harzianum, Zm Glp1 17 Protein From Zea Mays L., And Method For Preparing Transgenic Zea Mays L.

US20260078390A1 · SHANGHAI JIAO TONG UNIVERSITY · Mar 19, 2026
C12N A01N
Application

Method For Efficient Genetic Transformation And Gene Editing Of Brassica Crop Mediated By Agrobacterium Rhizogenes

US20260078389A1 · Mar 19, 2026
C12N C07K
Application

Insect Resistant Inir6 Transgenic Maize Plants Lacking A Selectable Marker And Junction

US20260078388A1 · Mar 19, 2026
C12N A01H
Application

Engineered Bacteria, Systems, And Methods For Degrading Polyester Materials

US20260078387A1 · Mar 19, 2026
C12N C08J
Application

Genetically Modified Microorganism, Method(s) And Application(s) Thereof

US20260078386A1 · Mar 19, 2026
C12N C07K
Application

Probiotics Designed To Express And Secrete Akkermansia Muciniphila Tars, And A Vector For Producing The Same

US20260078385A1 · Korea Research Institute of Bioscience and Biotechnolgy · Mar 19, 2026
C12N A61K
Application

Systems, Methods, And Compositions For An Inducible Promoter System

US20260078384A1 · Science Corporation · Mar 19, 2026
C12N C12N
Application

Rna Nanostructures And Methods Of Making And Using Rna Nanostructures

US20260078383A1 · Mar 19, 2026
C12N B82Y
Application

G Quadruplex Containing Oligonucleotides

US20260078382A1 · Mar 19, 2026
C12N A61K
Application

Methods For Directing Lipid Nanoparticles In Vivo

US20260078381A1 · Vertex Pharmaceuticals Incorporated · Mar 19, 2026
C12N C12N
Application

Trans Splicing Molecules

US20260078380A1 · Mar 19, 2026
C12N C07K
Application

Enzymes For Controlling Microbiologically Influenced Corrosion

US20260078294A1 · Mar 19, 2026
C09K C09K
Application

Urease Inhibiting Composition And Use Of Same

US20260078068A1 · FERTINAGRO BIOTECH, S.L. · Mar 19, 2026
C05G C05C
Application

Plant Fat Based Scaffolds For The Growth Of Cell Based Meats And Methods Of Making Such Products

US20260078323A1 · Mar 19, 2026
C12M A23L
Application

Regulatable Cell Surface Receptors And Related Compositions And Methods

US20260078164A1 · Mar 19, 2026
C07K A61K
Application

T Cell Receptor That Targets Egfr Mutation And Methods Of Using The Same

US20260078163A1 · Mar 19, 2026
C07K A61K
Application

Modified Cry1 Ca Toxins Useful For Control Of Insect Pests

US20260078153A1 · CORTEVA AGRISCIENCE LLC · Mar 19, 2026
C07K A01N
Application

Enzymatically Active Domains From Anti Staphylococcal Phage Proteins

US20260078152A1 · Mar 19, 2026
C07K A61K
Application

Mutated Glycoprotein Of Vesicular Stomatitis Virus

US20260078150A1 · Mar 19, 2026
C07K C12N
Application

Polypeptides Having Cholesterol Lowering Function In Soybean Protein Hydrolysate, Preparation Method Thereof, And Uses Thereof

US20260078145A1 · Mar 19, 2026
C07K A61P
Application

Use Of A Janus Kinase Inhibitor And A Telomerase Inhibitor For The Treatment Of Myeloproliferative Neoplasms

US20260078379A1 · Mar 19, 2026
C12N A61K
Application

Treatment Of Sepsis With Pcsk9 And Ldlr Modulators

US20260078378A1 · Mar 19, 2026
C12N A61P
Application

Construct Comprising Utr Sequence That Improves Intracellular Stability And Biosynthesis Of Mrna And Use Thereof

US20260078377A1 · THERAGEN BIO CO., LTD. · Mar 19, 2026
C12N A61K
Application

Oligonucleotides For The Treatment Of Breast Cancer

US20260078376A1 · Mar 19, 2026
C12N A61K
Application

Rn Ai Agents For Inhibiting Influenza A Viral Gene Expression, Compositions Thereof, And Methods Of Use

US20260078375A1 · Mar 19, 2026
C12N A61P
Application

Novel Self Cleaving Dnazymes And Selection Process

US20260078374A1 · Mar 19, 2026
C12N C12Q
Application

Cyclic Antisense Therapeutics

US20260078373A1 · Mar 19, 2026
C12N A61K
Application

Nucleic Acids For Inhibiting Expression Of Lpa In A Cell

US20260078372A1 · Mar 19, 2026
C12N C12N
Application

Calcium Channel 3.2 Inhibitory Peptides And Uses Thereof

US20260078371A1 · Mar 19, 2026
C12N C12N
Application

Self Circularization Rna Structure

US20260078370A1 · RZNOMICS INC. · Mar 19, 2026
C12N C12N
Application

Method Of Inhibiting Durotaxis And/Or Treating Fibrosis

US20260078369A1 · Mar 19, 2026
C12N A61K
Application

Methods And Compositions For Treating Pancreatic Cancer

US20260078368A1 · Mar 19, 2026
C12N A61P
Application

Methods And Systems For Characterizing Analytes From Individual Cells Or Cell Populations

US20260078367A1 · Mar 19, 2026
C12N
Application

Methods And Compositions For Rna Processing In Fixed Cells

US20260078366A1 · Mar 19, 2026
C12N
Application

Reagents And Methods For Molecular Barcoding

US20260078365A1 · Mar 19, 2026
C12N C12N
Application

Devices And Systems For Dna Capture

US20260078364A1 · Mar 19, 2026
C12N C12N
Application

Recombinant Carbonic Anhydrase Polypeptides And Methods Of Use Thereof

US20260078363A1 · Mar 19, 2026
C12N B01D
Application

Subtilisin Variants And Methods Related Thereto

US20260078362A1 · Mar 19, 2026
C12N C11D
Application

Dna Polymerase Based Genome Editing System And Method

US20260078361A1 · Mar 19, 2026
C12N C12N
Application

Engineered Proteins And Methods Of Use Thereof

US20260078360A1 · Mar 19, 2026
C12N C07K
Application

Polypeptides

US20260078359A1 · NOVOZYMES A/S · Mar 19, 2026
C12N C11D
Application

Dna Polymerase Mutant For Sequencing

US20260078358A1 · WUHAN MGI TECH CO., LTD. · Mar 19, 2026
C12N C12N
Application

Use Of Glycine Max Aspartate Kinase/Homoserine Dehydrogenase Family Gene Gm Ak Hsdh

US20260078357A1 · Mar 19, 2026
C12N C12N
Application

Compositions And Methods For Treating Ornithine Transcarbamylase Deficiency

US20260078356A1 · Mar 19, 2026
C12N A61P
Application

Rna Programmable Epigenetic Rna Modifiers And Uses Thereof

US20260078355A1 · The Broad Institute, Inc. · Mar 19, 2026
C12N C12N
Application

Ketoreductase Enzymes For The Synthesis Of 1,3 Diol Substituted Indanes

US20260078354A1 · Merck Sharp & Dohme LLC · Mar 19, 2026
C12N C12N
Application

Mammalian Cell Line For The Production Of Modified Vaccinia Virus Ankara (Mva)

US20260078353A1 · Bavarian Nordic A/S · Mar 19, 2026
C12N A61K
Application

Methods And Systems For Estimating Proportion Of Filled Virus Capsids Using Cryo Em

US20260078352A1 · Mar 19, 2026
C12N G01N
Application

Virus Production Method

US20260078351A1 · FUJIFILM Corporation · Mar 19, 2026
C12N C12N
Application

Adenovirus Associated Viruses Separation Method

US20260078350A1 · CYTIVA US LLC · Mar 19, 2026
C12N C12N
Application

Enhanced Adoptive Cell Therapy

US20260078349A1 · Mar 19, 2026
C12N A61K
Application

Multiple Myeloma Microorganospheres

US20260078348A1 · Mar 19, 2026
C12N G01N
Application

Clinical Derivations Of An Allogenic Cell And Therapeutic Uses

US20260078347A1 · Mar 19, 2026
C12N A61K
Application

Cell Tissue Production Method, Application Method And Application Device

US20260078346A1 · Mar 19, 2026
C12N C12M
Application

Method For Differentiating Stem Cells Into Hard Tissue

US20260078345A1 · Mar 19, 2026
C12N C12N
Application

Compositions For Promoting Activation Of Bone Marrow Derived Stem Cells Comprising Ccl5

US20260078344A1 · PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION · Mar 19, 2026
C12N A61K
Application

Engineered Cell And Application Thereof

US20260078343A1 · Mar 19, 2026
C12N C12N
Application

Modified Nk 92 Ha Nk003 Cells For The Clinic

US20260078342A1 · Mar 19, 2026
C12N A61K
Application

Treatment Of Cancer Using Chimeric Antigen Receptor

US20260078341A1 · Mar 19, 2026
C12N A61K
Application

Scaffolds With Stabilized Mhc Molecules For Immune Cell Manipulation

US20260078340A1 · Mar 19, 2026
C12N A61K
Application

Hla Triple Knockout Human Follicle Cells For Enhanced Hair Implantation Therapy With Integrated Biosensor System

US20260078339A1 · Mar 19, 2026
C12N C12N
Application

High Reactivity Hydrogel Particle And Preparation Method Therefor And Use Thereof

US20260078338A1 · Mar 19, 2026
C12N B33Y
Application

E. Coli Strains Having An Oxidative Cytoplasm

US20260078337A1 · Mar 19, 2026
C12N C07K
Application

Lactobacillus Acidophilus Goldgut La100 Having Functions Of Lipid Lowering, Blood Glucose Lowering And Weight Loss And Application Thereof

US20260078336A1 · Mar 19, 2026
C12N A61K
Application

Microbial Enhanced Compositions Comprising Surfactant Blends Which Overcome Antagonistic Surfactant Incompatibility

US20260078335A1 · Mar 19, 2026
C12N
Application

A Method For Producing Heat Killed Lactic Acid Bacteria Which Have An Improved Activity Of Immune Regulation

US20260078334A1 · CJ CHEILJEDANG CORPORATION · Mar 19, 2026
C12N A61K
Application

Method Of Isolating Animal Gonadal Mesenchymal Stem Cells

US20260078333A1 · Mar 19, 2026
C12M A61K
Application

Bacterial Compositions For Consuming Methane And Fixing Nitrogen

US20260077310A1 · Mar 19, 2026
B01D B01D
Application

Atp Independent Bioluminescent Reporter Variants To Improve In Vivo Imaging

US20260077068A1 · Mar 19, 2026
A61K C07D
Application

Compositions And Methods For Assessing Kinase Activity

US20260077065A1 · Mar 19, 2026
A61K A61K
Application

Optimized Cln1 Genes And Expression Cassettes And Their Use

US20260077064A1 · Mar 19, 2026
A61K C12N
Application

Universal Non Viral Gene Delivery System With Enhanced Stability

US20260077063A1 · Mar 19, 2026
A61K A61K
Application

Antibody Gene Therapy For Treatment And Prevention Of Infection By Rabies Lyssavirus

US20260077062A1 · Auburn University · Mar 19, 2026
A61K A61P
Application

Compositions And Methods For In Vivo Nuclease Mediated Gene Targeting For The Treatment Of Genetic Disorders In Adult Patients

US20260077061A1 · The Trustees of the University of Pennsylvania · Mar 19, 2026
A61K A61K
Application

Methods Of Treating Or Preventing Amyotrophic Lateral Sclerosis

US20260077060A1 · Rowan University · Mar 19, 2026
A61K C12N
Application

Anti Ghrelin Butyrylcholinesterase Enzyme Therapeutic

US20260077059A1 · Mar 19, 2026
A61K A61K
Application

Nucleic Acid Carrier And Method For Administering Nucleic Acid

US20260077057A1 · Mar 19, 2026
A61K A61K
Application

Compositions Of Polyplexes And Saponins

US20260077055A1 · Mar 19, 2026
A61K A61K
Application

Antibodies And Enonomers

US20260077053A1 · Mar 19, 2026
A61K A61K
Application

Compounds Including A Mutant Kras Sequence And A Lipid And Uses Thereof

US20260077049A1 · Mar 19, 2026
A61K A61K
Application

Method To Generate Improving Car T Cells

US20260077045A1 · Mar 19, 2026
A61K A61K
Application

Immunization Method Against Infection By Sars Co V 2

US20260077035A1 · Imam Abdulrahman Bin Faisal University · Mar 19, 2026
A61K A61K
Application

Multivalent Carriers And Related Vaccine Compositions

US20260077034A1 · Mar 19, 2026
A61K A61K
Application

Kari Nanoparticle

US20260077032A1 · La Jolla Institute for Immunology · Mar 19, 2026
A61K A61K
Application

Nucleic Acids Encoding Human Endogenous Retrovirus K (Herv K) Envelope Proteins Containing Modified Immunosuppressive Domains (Isd) And Uses Thereof

US20260077031A1 · INPROTHER APS · Mar 19, 2026
A61K A61K
Application

Membrane Vesicles Comprising Multiple Influenza Antigens For Vaccines

US20260077030A1 · Mar 19, 2026
A61K A61P
Application

Methods For Treating Netosis And Neutrophil Activation

US20260077028A1 · TRUSTEES OF BOSTON UNIVERSITY · Mar 19, 2026
A61K A61K
Application

Methods For Treating Cancer With Hyperactive Adar Enzymes

US20260077026A1 · THE UNIVERSITY OF CHICAGO · Mar 19, 2026
A61K A61K
Application

Sialylated Glycoprotein Composition And Uses Thereof

US20260077025A1 · Mar 19, 2026
A61K A61K
Application

Cellular Immunotherapy Compositions And Uses Thereof

US20260077015A1 · Mar 19, 2026
A61K A61K
Application

Complex With Stroke Therapeutic Characteristic, And Preparation Method And Use Thereof

US20260077010A1 · Beijing Technology and Business University · Mar 19, 2026
A61K A61K
Application

Oncolytic Virus Expressing An Immune Cell Engager For Tumor Targeting

US20260077006A1 · Mar 19, 2026
A61K A61P
Application

Lentiviral Vector Formulations

US20260077005A1 · Mar 19, 2026
A61K A61K
Application

Compositions And Methods For Treatment Of Cardiac Disorders

US20260077004A1 · University of Massachusetts · Mar 19, 2026
A61K A61K
Application

Lactobacillus Reuteri And Use, Composition, Drug And Food Thereof

US20260077003A1 · WISBIOM (BEIJING) Biotechnology Co., Ltd. · Mar 19, 2026
A61K A23C
Application

Bacterial Compositions And Methods Of Use

US20260077001A1 · Mar 19, 2026
A61K A61K
Application

Metabolic Modulation Of Intratumoral Cholesterol With Engineered Bacteria For The Treatment Of Cancers

US20260077000A1 · Mar 19, 2026
A61K A61K
Application

Preservation Of Pancreatic Islet Grafts In The Extrahepatic Space

US20260076999A1 · Mar 19, 2026
A61K A61K
Application

Cell Implant Including Biodegradable Porous Microwell With Stem Cell Derived Insulin Secreting Cell Aggregate Supported Therein, And Use Thereof

US20260076997A1 · Mar 19, 2026
A61K A61P
Application

Composition For Treating Spinal Cord Injury, Comprising Stem Cells Treated With Novel Compound

US20260076996A1 · YJ CERAPEUTICS INC. · Mar 19, 2026
A61K A61P
Application

Bispecific Chimeric Antigen Receptors Targeting Cd20 And Bcma

US20260076995A1 · ABELZETA INC. · Mar 19, 2026
A61K A61K
Application

Dsrna, Use Thereof And Preparation Method Therefor

US20260076990A1 · Mar 19, 2026
A61K A61K
Application

Self Degrading Enzyme Loaded Biologically Derived Particles

US20260077088A1 · CRANNMED LIMITED · Mar 19, 2026
A61L A61L
Application

Compositions And Methods Comprising Lipid Nanoparticle Vaccines That Elicit A Modulated Immune Response

US20260076905A1 · Mar 19, 2026
A61K A61K
Application

Oligonucleotides, Compositions And Methods Thereof

US20260076989A1 · Mar 19, 2026
A61K A61K
Application

Methods And Compositions For Reducing Damage To A Plant Or Plant Part

US20260076374A1 · Mar 19, 2026
A01N A01P
Application

L Dopa Microbiome Therapy

US20260076931A1 · Mar 19, 2026
A61K A61K
Application

Agent For Promoting Undifferentiation And Cryoprotective Agent Using Aprotic Zwitterion

US20260076359A1 · NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY · Mar 19, 2026
A01N C09K
Application

Transgenic Animal For Producing Diversified Antibodies That Have The Same Light Chain I

US20260076347A1 · Mar 19, 2026
A01K C07K
Application

Leuconostoc Pseudomesenteroides C18 X24 And Use Of The Strain For Producing Vegan Cheese From Fermented Pea Protein And Sucrose

US20260076383A1 · Cargill, Incorporated · Mar 19, 2026
A23C A23L